Concepedia
Statistics
Publications
17
Citations
1.8K
H-Index
16
Active since
1993
Affiliations
SciClone Pharmaceuticals (United States)(Current)
University of California, Irvine
University of Miami
Rosetta Stone (United States)
Jonathan Kil is an author at SciClone Pharmaceuticals (United States) specializing in medicine, pharmacology, and hearing science.
Publications per year
1993–2020
Gene disruption of p27 <sup>Kip1</sup> allows cell proliferation in the postnatal and adult organ of Corti
Hubert Löwenheim, David N. Furness, Jonathan Kil et al. · Proceedings of the National Academy of Sciences · 1999 · 365 citations · Full text
Life Sciences, Cell Biology, Molecular Genetics +17
Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial
Jonathan Kil, Edward Lobariñas, Christopher Spankovich et al. · The Lancet · 2017 · 258 citations
Health Professions, Audiology, Otolaryngology +12
Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia
Jan-Harry Cabungcal, Danielle S. Counotte, Eastman M. Lewis et al. · Neuron · 2014 · 197 citations · Full text
Medicine, Neuroscience, Pharmacology +8
Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen
Eric D. Lynch, Rende Gu, Carol Pierce et al. · Hearing Research · 2004 · 167 citations
Medicine, Pharmacology, Toxicology +10
Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase
Jonathan Kil, Carol Pierce, Huy Tran et al. · Hearing Research · 2006 · 137 citations
Life Sciences, Biochemistry, Neuroscience +14
1–5 of 17